company background image
PHAR

Colombo City Holdings COSE:PHAR.N0000 Stock Report

Last Price

LK₨800.00

Market Cap

LK₨1.0b

7D

-2.4%

1Y

-38.4%

Updated

13 Aug, 2022

Data

Company Financials
PHAR.N0000 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends1/6

PHAR.N0000 Stock Overview

Colombo City Holdings PLC operates in the real estate sector in Sri Lanka.

Colombo City Holdings Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Colombo City Holdings
Historical stock prices
Current Share PriceLK₨800.00
52 Week HighLK₨1,349.75
52 Week LowLK₨707.00
Beta-0.10
1 Month Change2.80%
3 Month Change-17.53%
1 Year Change-38.36%
3 Year Change2.42%
5 Year Change-18.77%
Change since IPO281.63%

Recent News & Updates

Shareholder Returns

PHAR.N0000LK Real EstateLK Market
7D-2.4%3.2%8.4%
1Y-38.4%-25.9%5.8%

Return vs Industry: PHAR.N0000 underperformed the LK Real Estate industry which returned -25.9% over the past year.

Return vs Market: PHAR.N0000 underperformed the LK Market which returned 5.8% over the past year.

Price Volatility

Is PHAR.N0000's price volatile compared to industry and market?
PHAR.N0000 volatility
PHAR.N0000 Average Weekly Movementn/a
Real Estate Industry Average Movement5.3%
Market Average Movement8.6%
10% most volatile stocks in LK Market13.6%
10% least volatile stocks in LK Market5.0%

Stable Share Price: Insufficient data to determine PHAR.N0000's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine PHAR.N0000's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1913n/aK. Narangodahttps://ambeonholdings.com/real-estate/

Colombo City Holdings PLC operates in the real estate sector in Sri Lanka. It rents commercial properties and dwelling flats. The company was formerly known as The Colombo Pharmacy Company PLC and changed its name to Colombo City Holdings PLC in June 2013.

Colombo City Holdings Fundamentals Summary

How do Colombo City Holdings's earnings and revenue compare to its market cap?
PHAR.N0000 fundamental statistics
Market CapLK₨1.02b
Earnings (TTM)LK₨29.26m
Revenue (TTM)LK₨617.91m

34.8x

P/E Ratio

1.6x

P/S Ratio

Is PHAR.N0000 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
PHAR.N0000 income statement (TTM)
RevenueLK₨617.91m
Cost of RevenueLK₨577.80m
Gross ProfitLK₨40.11m
Other ExpensesLK₨10.85m
EarningsLK₨29.26m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)22.99
Gross Margin6.49%
Net Profit Margin4.74%
Debt/Equity Ratio0.0%

How did PHAR.N0000 perform over the long term?

See historical performance and comparison

Dividends

6.2%

Current Dividend Yield

218%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is PHAR.N0000 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PHAR.N0000?

Other financial metrics that can be useful for relative valuation.

PHAR.N0000 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.6x
Enterprise Value/EBITDA35x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does PHAR.N0000's PE Ratio compare to its peers?

PHAR.N0000 PE Ratio vs Peers
The above table shows the PE ratio for PHAR.N0000 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average45.3x
MSL.N0000 Mercantile Shipping
160.7xn/aLK₨497.2m
ASCO.N0000 Lanka Realty Investments
3.2xn/aLK₨3.2b
ETWO.N0000 Equity Two
10.4xn/aLK₨1.1b
CSD.N0000 Seylan Developments
6.9xn/aLK₨1.9b
PHAR.N0000 Colombo City Holdings
34.8xn/aLK₨1.0b

Price-To-Earnings vs Peers: PHAR.N0000 is good value based on its Price-To-Earnings Ratio (34.8x) compared to the peer average (45.3x).


Price to Earnings Ratio vs Industry

How does PHAR.N0000's PE Ratio compare vs other companies in the Asian Real Estate Industry?

Price-To-Earnings vs Industry: PHAR.N0000 is expensive based on its Price-To-Earnings Ratio (34.8x) compared to the LK Real Estate industry average (7.2x)


Price to Earnings Ratio vs Fair Ratio

What is PHAR.N0000's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PHAR.N0000 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio34.8x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PHAR.N0000's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of PHAR.N0000 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PHAR.N0000 (LKR800) is trading above our estimate of fair value (LKR272.56)

Significantly Below Fair Value: PHAR.N0000 is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Colombo City Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


12.0%

Forecasted Real Estate industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Colombo City Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

Past Performance

How has Colombo City Holdings performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-40.8%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: PHAR.N0000 has a large one-off loss of LKR91.3M impacting its June 30 2022 financial results.

Growing Profit Margin: PHAR.N0000's current net profit margins (4.7%) are lower than last year (84.5%).


Past Earnings Growth Analysis

Earnings Trend: PHAR.N0000's earnings have declined by 40.8% per year over the past 5 years.

Accelerating Growth: PHAR.N0000's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: PHAR.N0000 had negative earnings growth (-31.1%) over the past year, making it difficult to compare to the Real Estate industry average (4.7%).


Return on Equity

High ROE: PHAR.N0000's Return on Equity (1.5%) is considered low.


Discover strong past performing companies

Financial Health

How is Colombo City Holdings's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: PHAR.N0000's short term assets (LKR825.6M) exceed its short term liabilities (LKR50.6M).

Long Term Liabilities: PHAR.N0000's short term assets (LKR825.6M) exceed its long term liabilities (LKR25.8M).


Debt to Equity History and Analysis

Debt Level: PHAR.N0000 is debt free.

Reducing Debt: PHAR.N0000 has no debt compared to 5 years ago when its debt to equity ratio was 0.3%.

Debt Coverage: PHAR.N0000 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: PHAR.N0000 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Dividend

What is Colombo City Holdings's current dividend yield, its reliability and sustainability?

Dividend Score

1/6

Dividend Score 1/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


6.25%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: PHAR.N0000's dividend (6.25%) is higher than the bottom 25% of dividend payers in the LK market (2.25%).

High Dividend: PHAR.N0000's dividend (6.25%) is low compared to the top 25% of dividend payers in the LK market (8.27%).


Stability and Growth of Payments

Stable Dividend: PHAR.N0000 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: PHAR.N0000's dividend payments have increased, but the company has only paid a dividend for 8 years.


Earnings Payout to Shareholders

Earnings Coverage: With its high payout ratio (217.5%), PHAR.N0000's dividend payments are not well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (182.4%), PHAR.N0000's dividend payments are not well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

6.3yrs

Average board tenure


CEO

K. Narangoda

1

Tenure

Dr. K. Sajeeva Narangoda serves as an Executive Director at Colombo City Holdings PLC since July 06, 2021 and has been its Chief Executive Officer since August 13, 2021. Dr. Narangoda was Group Chief Inves...


Board Members

Experienced Board: PHAR.N0000's board of directors are considered experienced (6.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Colombo City Holdings PLC's employee growth, exchange listings and data sources


Key Information

  • Name: Colombo City Holdings PLC
  • Ticker: PHAR.N0000
  • Exchange: COSE
  • Founded: 1913
  • Industry: Real Estate Operating Companies
  • Sector: Real Estate
  • Implied Market Cap: LK₨1.018b
  • Shares outstanding: 1.27m
  • Website: https://ambeonholdings.com/real-estate/

Location

  • Colombo City Holdings PLC
  • No. 10, Gothami Road
  • 5th Floor
  • Colombo
  • 8
  • Sri Lanka

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/13 00:00
End of Day Share Price2022/08/12 00:00
Earnings2022/06/30
Annual Earnings2022/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.